Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1128, pseudogene (RNU6-1128P) is a genomic DNA sequence that is homologous to the functional U6 small nuclear RNA gene, but is classified as a processed pseudogene[6][5]. The U6 snRNA gene family encodes components of the spliceosome essential for mRNA splicing[1][3], but pseudogenes such as RNU6-1128P arise through duplication and retrotransposition events and do not produce a functional snRNA transcript[4][5]. These pseudogenes may serve as markers of genome evolution and retrotransposon dynamics[4], but they have no known direct biological, pharmacological, or disease-related activity[6][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1128, pseudogene (RNU6-1128P).